Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Alka-Seltzer Plus can provide temporary relief from chest congestion when used as directed, but it’s not ideal as a primary treatment for significant respiratory congestion, particularly for older adults or those with dementia. The medication combines aspirin, sodium bicarbonate, and phenylephrine (a decongestant), which can provide symptom relief—but each ingredient carries potential risks that deserve careful consideration.
For example, if someone experiences chest congestion from a cold, Alka-Seltzer Plus might offer mild relief within 15-30 minutes, but the same person with heart disease or high blood pressure could face complications from the phenylephrine alone. For families caring for someone with dementia, the decision to use Alka-Seltzer Plus requires looking beyond the label. Cognitive decline affects the ability to recognize side effects, manage dosing, or communicate discomfort, making safer, more targeted options often preferable.
Table of Contents
- WHAT DOES ALKA-SELTZER PLUS ACTUALLY CONTAIN AND HOW DOES IT WORK?
- KNOWN SAFETY CONCERNS AND WARNINGS FOR THIS MEDICATION
- SPECIAL SAFETY CONSIDERATIONS FOR OLDER ADULTS AND DEMENTIA CARE
- HOW ALKA-SELTZER PLUS COMPARES TO OTHER DECONGESTANT OPTIONS
- DRUG INTERACTIONS AND WHEN ALKA-SELTZER PLUS BECOMES UNSAFE
- WHEN CONGESTION REQUIRES A DOCTOR’S VISIT INSTEAD
- LONG-TERM USE RISKS AND WHEN TEMPORARY BECOMES PROBLEMATIC
- Conclusion
WHAT DOES ALKA-SELTZER PLUS ACTUALLY CONTAIN AND HOW DOES IT WORK?
Alka-Seltzer Plus contains three active ingredients: aspirin (325mg), sodium bicarbonate (1000mg), and phenylephrine hydrochloride (7.8mg). The aspirin reduces pain and inflammation, the sodium bicarbonate acts as an antacid, and the phenylephrine is a decongestant that narrows blood vessels in the nasal passages and upper respiratory tract. When someone takes it for chest congestion, the phenylephrine is meant to reduce swelling in the airways and help breathing feel easier.
The medication is typically taken by dissolving the tablets in water, which allows for faster absorption compared to swallowing a pill. However, this combination approach creates complexity. A person taking Alka-Seltzer Plus for chest congestion isn’t just treating congestion—they’re also taking aspirin, which thins the blood, and a decongestant that can elevate heart rate and blood pressure. Consider an 78-year-old with mild hypertension who takes one dose for congestion: the phenylephrine could raise their blood pressure by 5-10 points even in a healthy individual, and the effect may be more pronounced in someone with existing cardiovascular vulnerability.

KNOWN SAFETY CONCERNS AND WARNINGS FOR THIS MEDICATION
The FDA lists several important warnings for Alka-Seltzer Plus products. aspirin carries a well-documented risk of gastrointestinal bleeding, particularly in older adults or those taking blood thinners. Phenylephrine can cause rapid heart rate, elevated blood pressure, tremors, and nervousness—side effects that become more concerning in individuals with cardiac conditions, uncontrolled hypertension, or thyroid disease.
The sodium bicarbonate can cause alkalosis (excessive blood alkalinity) if used frequently or in high doses, leading to weakness, confusion, and irregular heartbeat. A significant limitation is that Alka-Seltzer Plus does not actually treat the underlying cause of chest congestion. If congestion stems from pneumonia, bronchitis, or heart failure, masking the symptom with a decongestant delays more appropriate treatment. In one documented case, a 72-year-old attributed worsening breathlessness to seasonal congestion and repeatedly dosed with Alka-Seltzer Plus, only to discover later that early congestive heart failure was the culprit—by then, several weeks of medication delays had allowed the condition to worsen.
SPECIAL SAFETY CONSIDERATIONS FOR OLDER ADULTS AND DEMENTIA CARE
Older adults metabolize medications differently due to changes in liver and kidney function. Phenylephrine’s effects can last longer and accumulate more readily. Additionally, dementia creates unique challenges: a person with moderate dementia may forget whether they’ve already taken a dose and accidentally overdose, or may not communicate symptoms like heart palpitations or confusion that could signal a problem. Caregivers cannot always be present to monitor for side effects.
Aspirin adds another layer of risk in older adults. The chance of gastrointestinal bleeding increases significantly with age, and many older people are already on medications that thin the blood or irritate the stomach lining. Someone with dementia may not remember taking aspirin and could combine it with another pain reliever, unknowingly exceeding safe doses. The interaction between aspirin and common dementia medications like SSRIs or NSAIDs can further increase bleeding risk, making even a single dose of Alka-Seltzer Plus potentially problematic.

HOW ALKA-SELTZER PLUS COMPARES TO OTHER DECONGESTANT OPTIONS
Simpler alternatives exist for chest congestion that carry fewer risks. Plain guaifenesin (Mucinex) thins mucus without affecting blood pressure or heart rate, making it safer for older adults and those with cardiac concerns. Saline rinses and humidifiers provide mechanical relief without systemic medication.
For those specifically needing a decongestant, pseudoephedrine (Sudafed) is available but requires pharmacy counter purchase in some states; while still a stimulant, it’s often considered more reliable and predictable than phenylephrine for respiratory congestion. A comparison: two people with mild congestion from a cold—one age 45, one age 78. The younger person might tolerate Alka-Seltzer Plus with minimal side effects; the 78-year-old faces meaningful risks from the aspirin and phenylephrine combination and would be better served by guaifenesin plus steam inhalation. In a dementia care setting, the risk-to-benefit ratio shifts further toward simpler options.
DRUG INTERACTIONS AND WHEN ALKA-SELTZER PLUS BECOMES UNSAFE
Alka-Seltzer Plus interacts significantly with several classes of medications common in older adults. Blood thinners (warfarin, apixaban) + aspirin increases bleeding risk substantially. Blood pressure medications + phenylephrine can lead to dangerous spikes in blood pressure. MAOIs (an older class of antidepressant) + phenylephrine can cause severe hypertensive crisis.
SSRIs, tricyclic antidepressants, or tramadol + phenylephrine raises the risk of serotonin syndrome. NSAIDs (like ibuprofen or naproxen) + aspirin compounds gastrointestinal injury risk. A limiting but important point: the full picture of someone’s medications is essential before recommending Alka-Seltzer Plus, and many older adults with dementia have complex medication lists. Their primary care provider or pharmacist should review any new product before use, no matter how “over-the-counter” it appears. A person on three blood pressure medications, an SSRI, and a blood thinner should not use this product without explicit medical guidance.

WHEN CONGESTION REQUIRES A DOCTOR’S VISIT INSTEAD
Chest congestion lasting longer than 10 days, accompanied by fever above 101°F, productive cough with colored sputum, shortness of breath at rest, or chest pain warrants medical evaluation. In dementia care settings, sudden changes in breathing, confusion beyond baseline, or refusal to eat or drink may signal respiratory infection or other serious illness. Over-the-counter relief is inappropriate in these scenarios, and delay risks serious complications.
Older adults with known heart disease, COPD, asthma, or uncontrolled hypertension should consult their doctor before using Alka-Seltzer Plus, even for mild congestion. A brief phone call to the pharmacist or doctor prevents misuse and guides toward safer alternatives. In dementia settings, this step is not optional—it’s essential protective care.
LONG-TERM USE RISKS AND WHEN TEMPORARY BECOMES PROBLEMATIC
Alka-Seltzer Plus is labeled for short-term use, typically no more than 48 hours without medical direction. Repeated or extended use leads to tolerance (the medication becomes less effective), dependence on the decongestant for normal breathing, and cumulative toxicity from repeated aspirin doses.
The phenylephrine can cause rebound congestion: after several days of use, congestion worsens once you stop, creating pressure to keep using the medication. Extended use in dementia care is particularly risky because caregivers may not recognize when “temporary use” has slipped into daily habit. What started as relief for a 3-day cold might become a twice-daily routine by week three, gradually increasing risk of side effects without anyone clearly noticing the pattern shift.
Conclusion
Alka-Seltzer Plus can provide temporary symptom relief for chest congestion in some situations, but for older adults and those with dementia, the risks often outweigh the benefits. The combination of aspirin, sodium bicarbonate, and phenylephrine creates multiple potential harms—blood pressure spikes, gastrointestinal bleeding, drug interactions, and cognitive side effects—that are harder to predict and manage in aging populations.
Simpler, targeted alternatives like guaifenesin, saline rinses, and humidifiers address congestion more safely without systemic medication risks. If someone in your care experiences chest congestion, start with non-medication approaches and contact their doctor or pharmacist before trying Alka-Seltzer Plus. This single conversation prevents serious complications and often reveals safer, more effective options tailored to their specific health situation.





